phosphocitrate has been researched along with Calcinosis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanley, EN; Mauerhan, DR; Norton, HJ; Roberts, A; Sun, AR; Sun, Y | 1 |
| Cox, M; Haines, N; Hanley, EN; Ingram, J; Mauerhan, DR; Mihalko, KL; Roberts, A; Ruffolo, M; Sun, Y | 1 |
| Cooke, MM; McCarthy, GM; Morgan, MP; Sallis, JD | 1 |
| Cheung, HS; Sun, Y; Wenger, L; Zeng, XR | 1 |
| McCarthy, G | 1 |
| Cheung, HS; Demadis, KD; Sallis, JD; Wierzbicki, A | 1 |
| Crowden, S; Sallis, JD; Shankar, R | 1 |
| Howard, JE; Lehninger, AL; Malis, CD; Tew, WP | 1 |
| Kamperman, H; Sallis, JD | 1 |
| Cheung, HS; Sallis, JD; Struve, JA | 1 |
| Cheung, HS; Ryan, LM | 1 |
| Baran, P; Demadis, KD; Raptis, RG; Sallis, JD | 1 |
| Levy, RJ; Sallis, JD; Schoen, FJ; Shankar, R; Tsao, JW | 1 |
13 other study(ies) available for phosphocitrate and Calcinosis
| Article | Year |
|---|---|
Biological activities of phosphocitrate: a potential meniscal protective agent.
Topics: Calcinosis; Calcium; Cell Proliferation; Citrates; Collagen; Gene Expression; Humans; Joint Diseases; Knee Joint; Menisci, Tibial; Metabolic Networks and Pathways; Osteoarthritis; Prostaglandins; Vascular Diseases | 2013 |
Disease-modifying effects of phosphocitrate and phosphocitrate-β-ethyl ester on partial meniscectomy-induced osteoarthritis.
Topics: ADAM Proteins; Animals; Antirheumatic Agents; Calcinosis; Cartilage, Articular; Cell Proliferation; Cells, Cultured; Chemokine CCL5; Citrates; Cyclooxygenase 2; Disease Models, Animal; Dose-Response Relationship, Drug; Fibroblasts; Gene Expression Regulation; Guinea Pigs; Male; Matrix Metalloproteinase 13; Menisci, Tibial; Molecular Structure; Osteoarthritis; Structure-Activity Relationship; Synovial Membrane | 2015 |
Phosphocitrate inhibits calcium hydroxyapatite induced mitogenesis and upregulation of matrix metalloproteinase-1, interleukin-1beta and cyclooxygenase-2 mRNA in human breast cancer cell lines.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Breast Neoplasms; Calcinosis; Cell Division; Citrates; Cyclooxygenase 2; Dinoprostone; Durapatite; Gene Expression Regulation, Neoplastic; Humans; Interleukin-1; Isoenzymes; Macrolides; Matrix Metalloproteinase 1; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; RNA, Messenger; Tumor Cells, Cultured; Up-Regulation | 2003 |
Basic calcium phosphate crystals stimulate the endocytotic activity of cells--inhibition by anti-calcification agents.
Topics: Breast Neoplasms; Calcification, Physiologic; Calcinosis; Calcium; Calcium Phosphates; Cell Line, Tumor; Cell Membrane Permeability; Citrates; Crystallization; Dose-Response Relationship, Drug; Endocytosis; HeLa Cells; Humans; Minerals; Plasmids | 2003 |
New drugs for crystal deposition diseases.
Topics: Calcinosis; Calcium Compounds; Citrates; Gout; Gout Suppressants; Humans; Joints; Osteoarthritis; Uric Acid | 2006 |
Phosphocitrate blocks calcification-induced articular joint degeneration in a guinea pig model.
Topics: Animals; Calcinosis; Calcium; Cartilage, Articular; Citrates; Crystallization; Crystallography, X-Ray; Disease Models, Animal; Disease Progression; Guinea Pigs; Joints; Male; Menisci, Tibial; Osteoarthritis, Knee; Rabbits; Stifle | 2006 |
Phosphocitrate and its analogue N-sulpho-2-amino tricarballylate inhibit aortic calcification.
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Diseases; Arteriosclerosis; Calcinosis; Citrates; Electron Probe Microanalysis; Male; Microscopy, Electron; Rats; Rats, Inbred Strains; Tricarboxylic Acids | 1984 |
Phosphocitrate inhibits mitochondrial and cytosolic accumulation of calcium in kidney cells in vivo.
Topics: Animals; Calcinosis; Calcium; Calcium Gluconate; Citrates; Cytosol; Dose-Response Relationship, Drug; Kidney; Kidney Diseases; Male; Mice; Microscopy, Electron; Mitochondria; Parathyroid Hormone | 1981 |
Liposome and multiple emulsion formulations augment the anticalcifying efficacy of phosphocitrate in a cutaneous calcergy model.
Topics: Animals; Calcinosis; Chemistry, Pharmaceutical; Citrates; Disease Models, Animal; Drug Stability; Emulsions; Feasibility Studies; Liposomes; Male; Rats; Rats, Wistar; Skin Diseases | 1995 |
Specific inhibition of basic calcium phosphate and calcium pyrophosphate crystal-induction of metalloproteinase synthesis by phosphocitrate.
Topics: 1-Methyl-3-isobutylxanthine; Aged; Animals; Blotting, Northern; Blotting, Western; Calcinosis; Calcium Phosphates; Cells, Cultured; Citrates; Colforsin; Crystallization; Cyclic AMP; DNA; DNA Probes; Enzyme Induction; Fibroblasts; Genes, jun; Humans; Male; Matrix Metalloproteinase 3; Metalloendopeptidases; Morbidity; Proto-Oncogene Proteins c-jun; Skin | 1996 |
Phosphocitrate blocks nitric oxide-induced calcification of cartilage and chondrocyte-derived apoptotic bodies.
Topics: Animals; Apoptosis; Calcinosis; Cartilage; Chondrocalcinosis; Chondrocytes; Citrates; Nitric Oxide; Swine | 1999 |
A crystallographically characterized nine-coordinate calcium-phosphocitrate complex as calcification inhibitor in vivo.
Topics: Animals; Calcinosis; Calcium; Citrates; Crystallography, X-Ray; Male; Rats; Rats, Wistar | 2001 |
Retardation of calcification of bovine pericardium used in bioprosthetic heart valves by phosphocitrate and a synthetic analogue.
Topics: Animals; Biocompatible Materials; Calcinosis; Cattle; Citrates; Growth Plate; Heart Valve Prosthesis; Male; Pericardium; Rats; Rats, Inbred Strains; Tricarboxylic Acids | 1988 |